CATAPULT GROUP INTERNATIONAL LIMITED (CAT)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

CAT - CATAPULT GROUP INTERNATIONAL LIMITED

FNArena Sector : Medical Equipment & Devices

Year End: March

GICS Industry Group : Technology Hardware & Equipment

Debt/EBITDA: 2.06

Index: ALL-ORDS

Catapult Group develops and sells wearable sensors to monitor and analyse athletic performance, including fitness and skill levels, injury risks and rehabilitation assistance. It listed on the ASX in 2014.

LAST PRICE	CHANGE +/-	CHANGE %	VOLUME
$2.38 04 Oct 2024	-0.030 OPEN $2.42	-1.24% HIGH $2.44	235,480 LOW $2.37

LAST PRICE

CHANGE +/-

CHANGE %

VOLUME

$2.38

04 Oct
2024

-0.030

OPEN

$2.42

-1.24%

HIGH

$2.44

235,480

LOW

$2.37

TARGET

$2.35

-1.3% downside

OTHER COMPANIES IN THE SAME SECTOR
4DX . AT1 . AYA . BB1 . BRN . CBL . CGS . CMP . COH . CSX . CU6 . CVB . CYC . EBR . EMV . EYE . FPH . IDX . IME . IMR . IPD . LDX . MX1 . NAN . ONE . PCK . PEB . PGC . PME . RMD . SOM . TRJ . UBI . VTI .

FNARENA'S MARKET CONSENSUS FORECASTS

12 Month Avg FX Values

Present FX Values

Original Currency

Title	FY25 Forecast	FY26 Forecast
EPS (cps)	- 7.3	xxx
DPS (cps)	0.0	xxx
EPS Growth	N/A	xxx
DPS Growth	N/A	xxx
PE Ratio	N/A	xxx
Dividend Yield	0.0%	xxx
Div Pay Ratio(%)	N/A	xxx

Title	FY25 Forecast	FY26 Forecast
EPS (cps)	- 7.1	xxx
DPS (cps)	0.0	xxx
EPS Growth	N/A	xxx
DPS Growth	N/A	xxx
PE Ratio	N/A	xxx
Dividend Yield	0.0%	xxx
Div Pay Ratio(%)	N/A	xxx

Title	FY23 Actual	FY24 Actual	FY25 Forecast	FY26 Forecast
EPS (cps)	xxx	N/A	- 4.8	xxx
DPS (cps)	xxx	N/A	0.0	xxx
EPS Growth	xxx	N/A	N/A	xxx
DPS Growth	xxx	N/A	N/A	xxx
Div Pay Ratio(%)	xxx	N/A	N/A	xxx

This company reports in USD.
All estimates have been converted into AUD by FNArena at present FX values.

Dividend yield today if purchased 3 years ago: 0.00%

DIVIDEND YIELD CALCULATOR

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

HISTORICAL DATA ARE ALL IN AUD

Copyright © 2024 FactSet UK Limited. All rights reserved

Title	2018	2019	2021	2022	2023	2024
EPS Basic	xxx	xxx	xxx	xxx	xxx	-10.6
DPS All	xxx	xxx	xxx	xxx	xxx	0.0
Sales/Revenue	xxx	xxx	xxx	xxx	xxx	152.1 M
Book Value Per Share	xxx	xxx	xxx	xxx	xxx	48.3
Net Operating Cash Flow	xxx	xxx	xxx	xxx	xxx	45.4 M
Net Profit Margin	xxx	xxx	xxx	xxx	xxx	-16.68 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title	2018	2019	2021	2022	2023	2024
Return on Capital Employed	xxx	xxx	xxx	xxx	xxx	-20.36 %
Return on Invested Capital	xxx	xxx	xxx	xxx	xxx	-16.77 %
Return on Assets	xxx	xxx	xxx	xxx	xxx	-10.23 %
Return on Equity	xxx	xxx	xxx	xxx	xxx	-20.36 %
Return on Total Capital	xxx	xxx	xxx	xxx	xxx	-15.10 %
Free Cash Flow ex dividends	xxx	xxx	xxx	xxx	xxx	29.5 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title	2018	2019	2021	2022	2023	2024
Short-Term Debt	xxx	xxx	xxx	xxx	xxx	1 M
Long Term Debt	xxx	xxx	xxx	xxx	xxx	27 M
Total Debt	xxx	xxx	xxx	xxx	xxx	28 M
Goodwill - Gross	xxx	xxx	xxx	xxx	xxx	79 M
Cash & Equivalents - Generic	xxx	xxx	xxx	xxx	xxx	18 M
Price To Book Value	xxx	xxx	xxx	xxx	xxx	3.21

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title	2018	2019	2021	2022	2023	2024
Capex	xxx	xxx	xxx	xxx	xxx	41.1 M
Capex % of Sales	xxx	xxx	xxx	xxx	xxx	27.05 %
Cost of Goods Sold	xxx	xxx	xxx	xxx	xxx	148 M
Selling, General & Admin. Exp & Other	xxx	xxx	xxx	xxx	xxx	27 M
Research & Development	xxx	xxx	xxx	xxx	xxx	-
Investments - Total	xxx	xxx	xxx	xxx	xxx	0 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
EXTRA COVERAGE

EXPERT VIEWS

Display All Commentary

Sentiment Indicator

0.0

No. Of Recommendations

BROKER	DATE	RATING	RECOMMENDATION	TARGET PRICE	% TO REACH TARGET	COMMENTARY
Bell Potter	17/09/2024	3	Hold	$2.35	-1.26%	Bell Potter maintains its Hold rating for Catapult International but acknowledges this has been the wrong call so far as the stock has been one of the best performing in the mid-cap technology sector. Catapult shares have risen by more than 50% since the release of the FY24 result in late-May. In line with consensus forecasts, the analysts now forecast mid-teens revenue growth in each of the next three years, compared to low-to-mid teens previously. The broker's target price is raised to $2.35 from $1.75 on the higher revenue forecast, a higher assumed multiple, and a lower weighted average cost of capital (WACC). FORECAST Bell Potter forecasts a full year FY25 dividend of 0.00 cents and EPS of minus -7.27 cents. Bell Potter forecasts a full year FY26 dividend of 0.00 cents and EPS of minus -4.24 cents.

BROKER

DATE

RATING

RECOMMENDATION

TARGET PRICE

% TO REACH TARGET

COMMENTARY

Bell Potter

17/09/2024

Hold

$2.35

-1.26%

Bell Potter maintains its Hold rating for Catapult International but acknowledges this has been the wrong call so far as the stock has been one of the best performing in the mid-cap technology sector.

Catapult shares have risen by more than 50% since the release of the FY24 result in late-May.

In line with consensus forecasts, the analysts now forecast mid-teens revenue growth in each of the next three years, compared to low-to-mid teens previously.

The broker's target price is raised to $2.35 from $1.75 on the higher revenue forecast, a higher assumed multiple, and a lower weighted average cost of capital (WACC).

FORECAST
Bell Potter forecasts a full year FY25 dividend of 0.00 cents and EPS of minus -7.27 cents.
Bell Potter forecasts a full year FY26 dividend of 0.00 cents and EPS of minus -4.24 cents.

Access Stockbroker Research History >

EXTRA COVERAGE

Display All Commentary

No. Of Recommendations

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER	DATE	RATING	RECOMMENDATION	TARGET PRICE	% TO REACH TARGET	COMMENTARY

Access Extra Coverage Research History >

CAT STOCK CHART

FNArena News on CAT

1	Rudi’s View: Growth Is Not A Dirty Word Sep 25 2024 - Rudi's View

2	FNArena Corporate Results Monitor – 07-06-2024 Jun 07 2024 - Australia

3	Australian Broker Call Extra Edition – Nov 22, 2023 Nov 22 2023 - Daily Market Reports

4	FNArena Corporate Results Monitor – 16-11-2023 Nov 16 2023 - Australia

5	Australian Broker Call Extra Edition – May 30, 2023 May 30 2023 - Daily Market Reports

Latest Medical Equipment & Devices News

1	Dr Boreham’s Crucible: Pro Medicus Sep 04 2024 - Australia

2	Pro Medicus: Don’t Stop Me Now Aug 20 2024 - Technicals

3	Dr Boreham’s Crucible: Blinklab May 20 2024 - Small Caps

4	ResMed Silences The Doubters Apr 29 2024 - Australia

5	Dr Boreham’s Crucible: 4D Medical Apr 23 2024 - Small Caps

6	Uptrend Resumed For ResMed Mar 19 2024 - Technicals

7	Dr Boreham’s Crucible: Cochlear Feb 28 2024 - Australia

8	Rudi Interviewed: Ongoing Potential In Technology & Growth Feb 19 2024 - Rudi's View

9	Dr Boreham’s Crucible: Artrya Feb 15 2024 - Small Caps

10	ResMed Recovery Turns Into Hollywood Script Jan 31 2024 - Australia

Dividend Yield Today On Last Actual Payout :	0.00
Estimated Dividend Growth (Average Of Past Three Years)	%
Amount Invested	$
Tell Me The Dividend After This Many Years

	Yield	Yield on investment
This Year
Year 1
Year 2
Year 3
Year 4
Year

Get 2 Weeks free trial

Sign Up

Member Login

CATAPULT GROUP INTERNATIONAL LIMITED (CAT)
Share Price Analysis and Chart